131 related articles for article (PubMed ID: 12236565)
1. A critical review of control strategies against meningococcal meningitis epidemics in sub-Saharan African countries.
Chippaux JP; Debois H; Saliou P
Infection; 2002 Aug; 30(4):216-24. PubMed ID: 12236565
[TBL] [Abstract][Full Text] [Related]
2. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
Chippaux JP; Debois H; Saliou P
Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
[TBL] [Abstract][Full Text] [Related]
3. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
4. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis.
Parent du Châtelet I; Gessner BD; da Silva A
Vaccine; 2001 May; 19(25-26):3420-31. PubMed ID: 11348706
[TBL] [Abstract][Full Text] [Related]
6. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
Robbins JB; Towne DW; Gotschlich EC; Schneerson R
Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
[TBL] [Abstract][Full Text] [Related]
7. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.
Robbins JB; Schneerson R; Gotschlich EC; Mohammed I; Nasidi A; Chippaux JP; Bernardino L; Maiga MA
Bull World Health Organ; 2003; 81(10):745-50; discussion 751-5. PubMed ID: 14758435
[TBL] [Abstract][Full Text] [Related]
8. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
Sante; 2003; 13(4):215-23. PubMed ID: 15047438
[TBL] [Abstract][Full Text] [Related]
9. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
[TBL] [Abstract][Full Text] [Related]
10. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
11. A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.
Robbins JB; Schneerson R; Gotschlich EC
Pediatr Infect Dis J; 2000 Oct; 19(10):945-53. PubMed ID: 11055594
[No Abstract] [Full Text] [Related]
12. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
Soriano-Gabarró M; Rosenstein N; LaForce FM
J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
[TBL] [Abstract][Full Text] [Related]
14. The Meningitis Vaccine Project.
LaForce FM; Konde K; Viviani S; Préziosi MP
Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
[TBL] [Abstract][Full Text] [Related]
15. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].
Nicolas P
Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941
[TBL] [Abstract][Full Text] [Related]
16. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.
Greenwood BM
Rev Infect Dis; 1984; 6(3):374-89. PubMed ID: 6429812
[TBL] [Abstract][Full Text] [Related]
17. WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015.
World Health Organization
Vaccine; 2018 Jun; 36(24):3421-3422. PubMed ID: 28760613
[TBL] [Abstract][Full Text] [Related]
18. Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.
Miller MA; Shahab CK
Pharmacoeconomics; 2005; 23(4):333-43. PubMed ID: 15853434
[TBL] [Abstract][Full Text] [Related]
19. [Which vaccination strategies for African meningococcal meningitis?].
Saliou P; Debois H
Bull Soc Pathol Exot; 2002 Dec; 95(5):326-30. PubMed ID: 12696369
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
Miller MA; Wenger J; Rosenstein N; Perkins B
Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
